In pediatric AML, NUP98 rearrangement, special activating alteration of FLT3 (internal tandem duplication, ITD), and WT1 mutations confer poor prognosis and drive the clinician towards aHSCT. The gene discussed is WT1; the disease is acute myeloid leukemia.